Enhanced Expression of &bgr;3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling Through Nitric Oxide Synthase

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation

• Publication date

  2014-01-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.113.004940PMID 24190960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase.

  2012cited by this paper
• Protein Kinase G Iα Inhibits Pressure Overload–Induced Cardiac Remodeling and Is Required for the Cardioprotective Effect of Sildenafil In Vivo

  2012cited by this paper
• Regulation of Endothelial Nitric-oxide Synthase (NOS) S-Glutathionylation by Neuronal NOS

  2012cited by this paper
• Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling.

  2012cited by this paper
• Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade.

  2011cited by this paper
• Moderate Caveolin-1 Downregulation Prevents NADPH Oxidase–Dependent Endothelial Nitric Oxide Synthase Uncoupling by Angiotensin II in Endothelial Cells

  2011influential reference
• Exercise Protects Against Myocardial Ischemia–Reperfusion Injury via Stimulation of &bgr;3-Adrenergic Receptors and Increased Nitric Oxide Signaling: Role of Nitrite and Nitrosothiols

  2011cited by this paper
• Plasma Membrane Calcium Pump (PMCA4)-Neuronal Nitric-oxide Synthase Complex Regulates Cardiac Contractility through Modulation of a Compartmentalized Cyclic Nucleotide Microdomain*

  2011cited by this paper
• FRET measurements of intracellular cAMP concentrations and cAMP analog permeability in intact cells

  2011cited by this paper
• Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation.

  2011cited by this paper
• Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload.

  2011cited by this paper
• Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I

  2011cited by this paper
• Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload.

  2009cited by this paper
• Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor.

  2009cited by this paper
• Ventricular Phosphodiesterase-5 Expression Is Increased in Patients With Advanced Heart Failure and Contributes to Adverse Ventricular Remodeling After Myocardial Infarction in Mice

  2009cited by this paper
• A Review of Evidence-Based β-Blockers in Special Populations With Heart Failure

  2008cited by this paper
• A review of evidence-based beta-blockers in special populations with heart failure.

  2008cited by this paper
• Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness.

  2008cited by this paper
• AMPKalpha2 counteracts the development of cardiac hypertrophy induced by isoproterenol.

  2008cited by this paper
• Sepsis is associated with an upregulation of functional β3 adrenoceptors in the myocardium

  2007cited by this paper
• Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload.

  2007cited by this paper
• Protein kinase cascades in the regulation of cardiac hypertrophy.

  2005cited by this paper
• nNOS Gene Deletion Exacerbates Pathological Left Ventricular Remodeling and Functional Deterioration After Myocardial Infarction

  2005cited by this paper
• Oxygen, oxidative stress, hypoxia, and heart failure.

  2005cited by this paper
• Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

  2005cited by this paper
• Endothelial β3-Adrenoreceptors Mediate Nitric Oxide–Dependent Vasorelaxation of Coronary Microvessels in Response to the Third-Generation β-Blocker Nebivolol

  2005cited by this paper
• Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.

  2005cited by this paper
• Cardiomyocyte-Specific Overexpression of Nitric Oxide Synthase 3 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction

  2004influential reference
• Altered Calcium Handling Is Critically Involved in the Cardiotoxic Effects of Chronic &bgr;-Adrenergic Stimulation

  2004cited by this paper
• Cardiomyocyte-Restricted Overexpression of Endothelial Nitric Oxide Synthase (NOS3) Attenuates &bgr;-Adrenergic Stimulation and Reinforces Vagal Inhibition of Cardiac Contraction

  2004cited by this paper
• Endothelial &bgr;3-Adrenoceptors Mediate Vasorelaxation of Human Coronary Microarteries Through Nitric Oxide and Endothelium-Dependent Hyperpolarization

  2004cited by this paper
• β3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human β3-adrenergic receptor

  2003cited by this paper
• beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor.

  2003cited by this paper
• Antiadrenergic therapy of chronic heart failure: surprises and new opportunities.

  2003cited by this paper
• Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes

  2002cited by this paper
• Genetic Alterations That Inhibit In Vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress

  2002cited by this paper
• Upregulation of &bgr;3-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium

  2001cited by this paper
• Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy.

  2001cited by this paper
• The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts.

  2001cited by this paper
• The effect of diabetes on expression of β1-, β2-, and β3-Adrenoreceptors in rat hearts

  2001cited by this paper
• Augmentation of Cardiac Contractility Mediated by the Human &bgr;3-Adrenergic Receptor Overexpressed in the Hearts of Transgenic Mice

  2001cited by this paper
• beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility.

  2000cited by this paper
• Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing beta(2)-adrenergic receptors in the heart.

  2000cited by this paper
• Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

  1999cited by this paper
• The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.

  1998influential reference
• Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade.

  1998cited by this paper
• Functional beta3-adrenoceptor in the human heart.

  1996cited by this paper
• Endothelial Nitric Oxide Synthase Targeting to Caveolae

  1996cited by this paper
• Activation of the mitogen-activated protein kinase cascade by pertussis toxin-sensitive and -insensitive pathways in cultured ventricular cardiomyocytes.

  1995cited by this paper
• Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.

  1993cited by this paper
• Molecular characterization of the human beta 3-adrenergic receptor.

  1989cited by this paper
• Adrenergic receptors in the heart.

  1982cited by this paper

• Is Mirabegron-the novel beta 3 agonist-effective in patients with heart failure? A systematic review and meta-analysis of efficacy and safety.

  2026cites this paper
• Therapeutic Potential of the β3-Adrenergic Receptor and Its Ligands in Cardiovascular Diseases

  2025cites this paper
• Regulation, effects and monitoring of compartmented cGMP signalling in cardiomyocytes-current status.

  2025cites this paper
• An NRF2/β3-Adrenoreceptor Axis Drives a Sustained Antioxidant and Metabolic Rewiring Through the Pentose-Phosphate Pathway to Alleviate Cardiac Stress

  2025cites this paper
• Declining nitric oxide bioavailability in cardiovascular aging: mechanistic insights and emerging interventions

  2025cites this paper
• Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF

  2024cites this paper
• Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2

  2024cites this paper
• Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure

  2024cites this paper
• ENDOGENOUS β3-ADRENERGIC RECEPTOR ACTIVATION ALLEVIATES SEPSIS-INDUCED CARDIOMYOCYTE APOPTOSIS VIA PI3K/AKT SIGNALING PATHWAY

  2024cites this paper
• Genetic Mutations and Mitochondrial Redox Signaling as Modulating Factors in Hypertrophic Cardiomyopathy: A Scoping Review

  2024cites this paper
• Nitric Oxide Signaling and Sensing in Age-Related Diseases

  2024cites this paper
• β3-Adrenergic receptor overexpression in cardiomyocytes preconditions mitochondria to withstand ischemia–reperfusion injury

  2024cites this paper
• First-In-Man Trial of β3-Adrenoceptor Agonist Treatment in Chronic Heart Failure: Impact on Diastolic Function

  2024cites this paper
• Activation of β3-AR by mirabegron prevents aortic dissection/aneurysm by promoting lymphangiogenesis in perivascular adipose tissue.

  2024cites this paper
• A Review of Therapeutic Approaches for Post-Infarction Left Ventricular Remodeling.

  2024cites this paper
• Red blood cell endothelial nitric oxide synthase: A major player in regulating cardiovascular health

  2023cites this paper
• The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies

  2023cites this paper
• Cardiac Adrenergic Receptors and GRKs: Mitochondrial Modulation in the Heart

  2023cites this paper
• Continuous short-term acclimation to moderate cold elicits cardioprotection in rats, and alters β-adrenergic signaling and immune status

  2023cites this paper
• Status of β1-Adrenoceptor Signal Transduction System in Cardiac Hypertrophy and Heart Failure

  2023cites this paper
• Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease

  2023cites this paper
• Clinical pharmacology of β-3 adrenergic receptor agonists for cardiovascular diseases

  2023cites this paper
• Modulation of the nitric oxide/cGMP pathway in cardiac contraction and relaxation: potential role in heart failure treatment.

  2023cites this paper
• Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model

  2022cites this paper
• Pathophysiology and pharmacology of G protein-coupled receptors in the heart.

  2022cites this paper
• Beta-3 adrenergic receptor overexpression reverses aortic stenosis–induced heart failure and restores balanced mitochondrial dynamics

  2022cites this paper
• β3 adrenoceptor agonist mirabegron protects against right ventricular remodeling and drives Drp1 inhibition

  2022cites this paper
• β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE‐HF): a double blind, placebo‐controlled, randomized clinical trial

  2022cites this paper
• Compartmentation of cGMP Signaling in Induced Pluripotent Stem Cell Derived Cardiomyocytes during Prolonged Culture

  2022cites this paper
• Editorial: Myocardial Remodeling: Mechanisms and Translational Implications

  2022cites this paper
• The Endothelial Dysfunction Could Be a Cause of Heart Failure with Preserved Ejection Fraction Development in a Rat Model

  2022cites this paper
• Regulation of bFGF-induced effects on rat aortic smooth muscle cells by β3-adrenergic receptors

  2022cites this paper
• Beta3-Adrenergic Receptor Activation Alleviates Cardiac Dysfunction in Cardiac Hypertrophy by Regulating Oxidative Stress

  2021cites this paper
• Multifaceted remodelling of cAMP microdomains driven by different aetiologies of heart failure

  2021cites this paper
• Rise of cGMP by partial phosphodiesterase-3A degradation enhances cardioprotection during hypoxia

  2021cites this paper
• Assembling fats and sugar for cardiac protection.

  2021cites this paper
• Electrophysiological Remodeling: Cardiac T-Tubules and ß-Adrenoceptors

  2021cites this paper
• Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy

  2021cites this paper
• Heart failure with preserved ejection fraction based on aging and comorbidities

  2021cites this paper
• Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure

  2021cites this paper
• Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease

  2021cites this paper
• Effect of β1/β2‐adrenoceptor blockade on β3‐adrenoceptor activity in the rat cremaster muscle artery

  2021cites this paper
• Recent Advances in β2-Agonists for Treatment of Chronic Respiratory Diseases and Heart Failure.

  2020cites this paper
• Healthful Aging Mediated by Inhibition of Oxidative Stress.

  2020cites this paper
• Overexpression of endothelial β3‐adrenergic receptor induces diastolic dysfunction in rats

  2020influential citation
• Cardiac cGMP signaling in health and disease: location, location, location.

  2020cites this paper
• Modelling the Impact of Chronic Cigarette Smoke Exposure in Obese Mice: Metabolic, Pulmonary, Intestinal, and Cardiac Issues

  2020cites this paper
• β3-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes

  2020cites this paper
• Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction

  2020cites this paper
• β3-Adrenergic Receptor Agonist Prevents Diastolic Dysfunction in an Angiotensin II–Induced Cardiomyopathy Mouse Model

  2020cites this paper
• Early nebivolol treatment is beneficial in myocardial infarction in rats partly through β3‐adrenoceptor remodelling

  2020cites this paper
• The Beta3 Adrenergic Receptor in Healthy and Pathological Cardiovascular Tissues

  2020cites this paper
• Expression and Signaling of β-Adrenoceptor Subtypes in the Diabetic Heart

  2020cites this paper
• The nutrient sensing pathways FoxO1/3 and mTOR in the heart are coordinately regulated by central leptin through PPARβ/δ. Implications in cardiac remodeling.

  2020cites this paper
• Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension

  2020cites this paper
• Nouvelles approches pour l’analyse morphologique du cœur sain et pathologique

  2020cites this paper
• β-adrenergic activation may promote myosin light chain kinase degradation through calpain in pressure overload-induced cardiac hypertrophy: β-adrenergic activation results in MLCK degradation.

  2020cites this paper
• The endocrinological component and signaling pathways associated to cardiac hypertrophy.

  2020cites this paper
• Recently Approved and Under Investigation Drugs for Treating Patients with Heart Failure

  2020cites this paper
• Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension

  2020cites this paper
• Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial

  2020cites this paper
• Beta 3 adrenoreceptors protect from hypertrophic remodelling through AMP‐activated protein kinase and autophagy

  2020influential citation
• Beta-3 Adrenoreceptors protect from hypertrophic remodelling through AMP-Activated Protein Kinase and Autophagy

  2020cites this paper
• Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future

  2020cites this paper
• Gradual cold acclimation induces cardioprotection without affecting beta-adrenergic receptor-mediated adenylyl cyclase signaling.

  2020cites this paper
• Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

  2019cites this paper
• Pathological cardiac hypertrophy: the synergy of adenylyl cyclases inhibition in cardiac and immune cells during chronic catecholamine stress

  2019cites this paper
• Beta-3 adrenoceptors: A potential therapeutic target for heart disease.

  2019cites this paper
• Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models

  2019cites this paper
• Phosphocreatine Attenuates Isoproterenol-Induced Cardiac Fibrosis and Cardiomyocyte Apoptosis

  2019cites this paper
• Brain cholesterol metabolite 24‐hydroxycholesterol modulates inotropic responses to &bgr;‐adrenoceptor stimulation: The role of NO and phosphodiesterase

  2019cites this paper
• Effects of tetrahydrobiopterin combined with nebivolol on cardiac diastolic function in SHRs.

  2019cites this paper
• Changes of Metabolic Phenotype of Cardiac Progenitor Cells During Differentiation: Neutral Effect of Stimulation of AMP-Activated Protein Kinase

  2019cites this paper
• Beta-3 Receptor Agonists

  2019cites this paper
• cGMP signalling in cardiomyocyte microdomains.

  2019cites this paper
• Everything You Always Wanted to Know about β3-AR * (* But Were Afraid to Ask)

  2019cites this paper
• Left ventricular remodelling in chronic primary mitral regurgitation: implications for medical therapy

  2018cites this paper
• Nitric oxide signalling in cardiovascular health and disease

  2018cites this paper
• Studying the Role of AMPK in Cardiac Hypertrophy and Protein Synthesis.

  2018cites this paper
• cGMP Signaling in the Cardiovascular System—The Role of Compartmentation and Its Live Cell Imaging

  2018cites this paper
• Aucubin protects against pressure overload‐induced cardiac remodelling via the β3‐adrenoceptor–neuronal NOS cascades

  2018cites this paper
• The Trend of β3-Adrenergic Receptor in the Development of Septic Myocardial Depression: A Lipopolysaccharide-Induced Rat Septic Shock Model

  2018cites this paper
• Measurement of cGMP-generating and -degrading activities and cGMP levels in cells and tissues: Focus on FRET-based cGMP indicators.

  2018cites this paper
• Role of the β3-adrenergic receptor subtype in catecholamine-induced myocardial remodeling

  2018cites this paper
• β3-adrenergic receptor activation induces TGFβ1 expression in cardiomyocytes via the PKG/JNK/c-Jun pathway.

  2018cites this paper
• Relaxin Family Member Insulin‐Like Peptide 6 Ameliorates Cardiac Fibrosis and Prevents Cardiac Remodeling in Murine Heart Failure Models

  2018cites this paper
• Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology

  2018cites this paper
• Rationale and design of a multicentre, randomized, placebo‐controlled trial of mirabegron, a Beta3‐adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3‐left ventricular hypertrophy (Beta3‐LVH)

  2018cites this paper
• Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction

  2018cites this paper
• New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging

  2018cites this paper
• Alteration of β-Adrenoceptor Signaling in Left Ventricle of Acute Phase Takotsubo Syndrome: a Human Study

  2018cites this paper
• Mst1 knockout enhances cardiomyocyte autophagic flux to alleviate angiotensin II-induced cardiac injury independent of angiotensin II receptors.

  2018cites this paper
• The effect of mirabegron on bladder blood flow in a rat model of bladder outlet obstruction

  2018cites this paper
• Cardiac myocyte &bgr;3-adrenergic receptors prevent myocardial fibrosis by modulating oxidant stress-dependent paracrine signaling

  2018cites this paper
• Response to 'The potential multiple effects of beta3-adrenergic receptor agonists on the heart protection for patients with heart failure with preserved ejection fraction'.

  2018cites this paper
• Mirabegron: potential off target effects and uses beyond the bladder

  2018cites this paper
• Cardiac beta3‐adrenergic receptors in the clinical arena: the end of the beginning

  2017cites this paper
• Nitric Oxide Regulation of Cardiovascular Physiology and Pathophysiology

  2017cites this paper
• Receptor-Cyclic Nucleotide Microdomains in the Heart

  2017cites this paper
• Potential Role for the Sarcolemmal Membrane Associated Protein Isoform 3 (SLMAP3) in Cardiac Remodeling Post Myocardial Infarction

  2017cites this paper